Janux Therapeutics Announces Closing of Underwritten Public Offering of Common Stock and Pre-Funded Warrants Including Full Exercise of Underwriters’ Option to Purchase Additional Shares for Total G Dec 6, 2024 07:43PM
Janux Therapeutics (JANX) Prices 5.32M Share Offering at $63/sh Dec 5, 2024 06:05AM
Janux Therapeutics Announces Pricing of $350.0 Million Underwritten Public Offering of Common Stock and Pre-Funded Warrants Dec 4, 2024 11:12PM
Janux Therapeutics (JANX) Announces Proposed $300M Share Offering Dec 3, 2024 04:02PM
Janux Therapeutics Announces Proposed Public Offering Dec 3, 2024 04:01PM


Dec 3, 2024 08:50AM TD Cowen Reiterates Buy on Janux Therapeutics (JANX) as JANX007 'Far Exceeds High Expectations'
Feb 29, 2024 05:50AM Janux Therapeutics (JANX) Prices $296.5M Share and Warrant Offering at $46.50/sh
Feb 29, 2024 01:22AM Janux Therapeutics Announces Pricing of $296.5 Million Underwritten Public Offering of Common Stock and Pre-Funded Warrants
Feb 27, 2024 05:00PM Janux Therapeutics (JANX) Announces Proposed $175M Share Offering
Feb 27, 2024 05:00PM Janux Therapeutics Announces Proposed Public Offering of Common Stock
Feb 14, 2023 12:00PM Janux Therapeutics to Participate in Novel IO Panel Discussion at Cowen's 43rd Annual Health Care Conference
Nov 10, 2022 04:01PM Janux Therapeutics Reports Third Quarter 2022 Financial Results and Business Highlights
Mar 1, 2022 08:01AM Janux Therapeutics to Present at Upcoming March Investor Conferences
Nov 8, 2021 08:00AM Janux Therapeutics to Present Virtually at Upcoming Investor Conferences
Jul 6, 2021 05:46AM Cowen Starts Janux Therapeutics (JANX) at Outperform
Jun 15, 2021 04:01PM Janux Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Jun 11, 2021 10:57AM Janux Therapeutics (JANX) IPO Doubles on Open